We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.
- Authors
Sekiguchi, Yukari; Misawa, Sonoko; Shibuya, Kazumoto; Nasu, Saiko; Mitsuma, Satsuki; Iwai, Yuta; Beppu, Minako; Sawai, Setsu; Ito, Shoichi; Hirano, Shigeki; Nakaseko, Chiaki; Kuwabara, Satoshi
- Abstract
Vascular endothelial growth factor (VEGF) plays an essential role in the pathophysiology of polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS) syndrome. Anti-VEGF antibody (bevacizumab) appears to be an attractive therapeutic option. The aim of this study is to investigate the effects of bevacizumab for patients with POEMS syndrome.
- Publication
Journal of neurology, neurosurgery, and psychiatry, 2013, Vol 84, Issue 12, p1346
- ISSN
1468-330X
- Publication type
Journal Article
- DOI
10.1136/jnnp-2012-304874